Topics:

Multiple sclerosis

Multiple Sclerosis and the Radiologically Isolated Syndrome

Do you have a patient with "radiologically isolated syndrome" -- and, if so, what do you tell your patient?
 

(Image courtesy Dr Frank Gaillard, http://radiopaedia.org)

FsdffsdFor people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability. - See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.Aq5cH0PQ.dpuf

MS and Cigarettes: Where There’s Smoke, There’s Disease Progression

For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.

- See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.P3SjVoYj.dpuf

For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.

- See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.P3SjVoYj.dpuf
For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability. - See more at: http://www.neurologytimes.com/multiple-sclerosis#sthash.Aq5cH0PQ.dpuf

Multiple sclerosis

What is the function of continued adult myelination in the normal undiseased brain? A recent study sheds remarkable light on this process and its importance.

Several new studies feature developments in remyelination in MS. Oligodendrocyte precursor cells may be a promising target for MS treatments, and microRNA expression are perhaps an attractive MS biomarker.

Is fatigue with MS related to diet? Is alcohol intake tied to lower MS disability and severity? Researchers at AAN 2015 reported on how patients are affected by what they eat and drink.

Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.

©Tewan Banditrukkanka/Shutterstock.com

Can the EEG predict neurological outcomes in post-anoxic encephalopathy from out-of-hospital cardiac arrest? What effect does TIA have on stroke risk in women migraineurs? What's the relationship between MS and vitamin D levels in minority populations?

A switch to a second-line drug in a patient receiving first-line therapies likely will be effective at decreasing disease activity.

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Pages

Subscribe to Multiple sclerosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.